Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations
about
Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations
description
wetenschappelijk artikel
@nl
name
Management of Adrenal Insuffic ...... nical Practice Recommendations
@en
Management of Adrenal Insuffic ...... nical Practice Recommendations
@nl
type
label
Management of Adrenal Insuffic ...... nical Practice Recommendations
@en
Management of Adrenal Insuffic ...... nical Practice Recommendations
@nl
prefLabel
Management of Adrenal Insuffic ...... nical Practice Recommendations
@en
Management of Adrenal Insuffic ...... nical Practice Recommendations
@nl
P2093
P921
P356
P1476
Management of Adrenal Insuffic ...... nical Practice Recommendations
@en
P2093
Anne M Connolly
Kathi Kinnett
Philip S Zeitler
Sasigarn A Bowden
P356
10.3233/JND-180346